Table 1 Baseline characteristics of Subjects
Parameter | PCAD (N = 57) | Controls (N = 57) | P value |
|---|---|---|---|
Age (yrs) | 43.1 ± 6.36 | 39.8 ± 6.13 | 0.125 |
Height (cm) | 165.8 ± 5.63 | 168.9 ± 6.99 | 0.008 |
Weight (kg) | 69.1 ± 11.25 | 69.2 ± 12.30 | 0.959 |
BMI (kg/m 2 ) | 24.8 ± 3.96 | 24.2 ± 3.91 | 0.472 |
Family history for CAD (n) (%) | 18 (31.6) | 6 (10.5) | 0.006 |
Family history for hypertension (n) (%N) | 2 (3.5) | 6 (10.5) | 0.142 |
SBP (mmHg) | 127.9 ± 11.88 | 127.46 ± 14.87 | 0.855 |
DBP (mmHg) | 83.4 ± 6.82 | 81.8 ± 8.95 | 0.290 |
Statins, n (%) | 36 (63.0) | 7 (12.0) | <0.001 |
ACE – Inhibitors, n (%) | 21 (37.0) | 6 (10.5) | <0.001 |
ß – blockers, n (%) | 28 (49.0) | 2 (3.5) | <0.001 |
Aspirin, n (%) | 41 (72.0) | 10 (17.5) | <0.001 |
PPAR-γ agonists n (%) | 1 (2.0) | 0 (0.0) | 0.229 |
LVEF% (mean ± SD) | 44.6 ± 1.77 | 60.40 ± 1.56 | 0.001 |
Diabetes n (%) | 9 (15.8) | -- | Â |
Hypertension, n (%) | 13 (22.8) | 14 (24.6) | 0.785 |
Smoking, n (%) | 24 (42.1) | 14 (24.6) | 0.047 |
Alcohol, n (%) | 11 (19.3) | 16 (28.1) | 0.083 |